The cash flow of AtriCure, Inc. over the past 10 years
Chart AtriCure, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, AtriCure, Inc.'s operating cash flow was $57.33M and its capital expenditures $9.05M, leaving free cash flow of $48.28M. Free cash flow was above zero in 2 of the 10 years shown. It ranged from -$39.02M in fiscal 2022 to $48.28M in fiscal 2025. Capital expenditures were highest in fiscal 2022, at $16.88M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $57.33M | $9.05M | $48.28M |
| 2024ended Dec 31, 2024 | $12.2M | $11.46M | $745K |
| 2023ended Dec 31, 2023 | $4.48M | $12M | -$7.51M |
| 2022ended Dec 31, 2022 | -$22.14M | $16.88M | -$39.02M |
| 2021ended Dec 31, 2021 | -$13.78M | $9.75M | -$23.53M |
| 2020ended Dec 31, 2020 | -$19.87M | $5.26M | -$25.13M |
| 2019ended Dec 31, 2019 | -$15.81M | $12.18M | -$27.99M |
| 2018ended Dec 31, 2018 | -$4.17M | $6.21M | -$10.38M |
| 2017ended Dec 31, 2017 | -$8.94M | $6.38M | -$15.33M |
| 2016ended Dec 31, 2016 | -$15.12M | $7.69M | -$22.81M |
Fiscal years as AtriCure, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AtriCure, Inc.
- The revenue of AtriCure, Inc.
- The profitability of AtriCure, Inc.
- The debt of AtriCure, Inc.
- All of AtriCure, Inc.'s financials, charted
Companies of a similar size
- IRONDisc Medicine, Inc.
- TMDXTransMedics Group, Inc.
- NMRKNEWMARK GROUP, INC.
- WDFCWD-40 COMPANY
- GPIGroup 1 Automotive, Inc
Not investment advice. This page shows what AtriCure, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.